🇺🇸 FDA
Patent

US 8337866

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia

granted A61KA61K2039/53A61K39/00

Quick answer

US patent 8337866 (Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia) held by The Regents of the University of California expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/53, A61K39/00, A61K39/118, A61P